175 related articles for article (PubMed ID: 21883889)
1. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study.
Chen H; Song Z; Qian M; Bai C; Wang X
J Cell Mol Med; 2012 Jun; 16(6):1286-97. PubMed ID: 21883889
[TBL] [Abstract][Full Text] [Related]
2. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation.
Chen H; Wang Y; Bai C; Wang X
J Proteomics; 2012 Jun; 75(10):2835-43. PubMed ID: 22343073
[TBL] [Abstract][Full Text] [Related]
3. Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics.
Shi L; Zhu B; Xu M; Wang X
Cell Biol Toxicol; 2018 Apr; 34(2):109-123. PubMed ID: 28779230
[TBL] [Abstract][Full Text] [Related]
4. Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia.
Chen C; Shi L; Li Y; Wang X; Yang S
Cell Biol Toxicol; 2016 Jun; 32(3):169-84. PubMed ID: 27095254
[TBL] [Abstract][Full Text] [Related]
5. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.
Gao W; Gao L; Yang F; Li Z
J Clin Lab Anal; 2022 Jan; 36(1):e24153. PubMed ID: 34918391
[TBL] [Abstract][Full Text] [Related]
6. Protein Network Analysis Identifies Changes in the Level of Proteins Involved in Platelet Degranulation, Proteolysis and Cholesterol Metabolism Pathways in AECOPD Patients.
Tan DBA; Ito J; Peters K; Livk A; Lipscombe RJ; Casey TM; Moodley YP
COPD; 2020 Feb; 17(1):29-33. PubMed ID: 31920121
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation.
Tan DBA; Armitage J; Teo TH; Ong NE; Shin H; Moodley YP
Respir Med; 2017 Nov; 132():261-264. PubMed ID: 28476471
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Blood Profiles Obtained by Totally Blind Biological Clustering in Stable and Exacerbated COPD Patients.
Enríquez-Rodríguez CJ; Pascual-Guardia S; Casadevall C; Caguana-Vélez OA; Rodríguez-Chiaradia D; Barreiro E; Gea J
Cells; 2024 May; 13(10):. PubMed ID: 38786086
[TBL] [Abstract][Full Text] [Related]
9. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
Ju CR; Liu W; Chen RC
Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
[TBL] [Abstract][Full Text] [Related]
10. Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease.
Chen X; Liu J; Zhu M; Hu B; Bai F; Jin W; Zhou J; Chen C; Song Y; Pan J
Clin Respir J; 2018 Oct; 12(10):2525-2533. PubMed ID: 30099848
[TBL] [Abstract][Full Text] [Related]
11. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease.
Liu X; Zhang H; Si Y; Du Y; Wu J; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123278. PubMed ID: 35561641
[TBL] [Abstract][Full Text] [Related]
12. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines.
Wang C; Feng D; Dong S; He R; Fan B
J Clin Lab Anal; 2022 Mar; 36(3):e24204. PubMed ID: 35064606
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines.
Hu HL; Nie ZQ; Lu Y; Yang X; Song C; Chen H; Zhu S; Chen BB; Huang J; Geng S; Zhao S
Medicine (Baltimore); 2017 Dec; 96(51):e9059. PubMed ID: 29390434
[TBL] [Abstract][Full Text] [Related]
15. Serum MCP-1 and NGAL Play an Important Role in the Acute Inflammatory Event of Chronic Obstructive Pulmonary Disease.
Chen XR; Wang DX
COPD; 2021 Aug; 18(4):425-431. PubMed ID: 34325599
[TBL] [Abstract][Full Text] [Related]
16. Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD.
Ghobadi H; Hosseini N; Aslani MR
Lung; 2020 Jun; 198(3):515-523. PubMed ID: 32211977
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a.
Wang Y; Lyu X; Wu X; Yu L; Hu K
J Clin Lab Anal; 2020 Aug; 34(8):e23346. PubMed ID: 32342557
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD.
Aslani MR; Ghazaei Z; Ghobadi H
Turk J Med Sci; 2020 Apr; 50(2):337-345. PubMed ID: 31905499
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
